Vasoactive intestinal peptide is a local regulator of adrenocortical function

被引:6
|
作者
Hinson, JP [1 ]
Ho, MM [1 ]
Vinson, GP [1 ]
Kapas, S [1 ]
机构
[1] ST BARTHOLOMEWS & ROYAL LONDON HOSP, DEPT ORAL PATHOL, SCH MED & DENT, LONDON E1 2AD, ENGLAND
关键词
D O I
10.1080/07435809609043782
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several immunohistochemical studies have shown that vasoactive intestinal peptide (VIP) is present in nerve terminals supplying the adrenal capsule and zona glomerulosa, but its function in this tissue has been unclear. Using the intact perfused rat adrenal preparation we showed that VIP is a vasodilator in this tissue, and stimulates aldosterone and corticosterone secretion. The effects of VIP are dependent on the tissue preparation used, and we have evidence that the effect on aldosterone secretion is secondary to local catecholamine release. Administration of a low sodium diet greatly enhanced the aldosterone response to VIP stimulation. Receptor binding studies reveal an increase in the number of VIP receptors in zona glomerulosa tissue in the low sodium group. We have also investigated the regulation of adrenal tissue content of VIP. The low sodium diet caused an increase in peptide content, while a high sodium diet had the opposite effect. Splanchnic nerve section, on the other hand, had no effect on zona glomerulosa VIP content. These findings suggest that adrenal VIP has a significant role in the regulation of zona glomerulosa function, particularly in response to altered electrolyte balance.
引用
收藏
页码:831 / 838
页数:8
相关论文
共 50 条
  • [41] VASOACTIVE INTESTINAL PEPTIDE IN BOWEL ISCHEMIA
    MODLIN, IM
    MITCHELL, S
    BLOOM, SR
    POLAK, JM
    EUROPEAN SURGICAL RESEARCH, 1977, 9 : 15 - 15
  • [42] VASOACTIVE INTESTINAL PEPTIDE AND COMPRESSION NEUROPATHY
    RAYAN, GM
    CAHILL, SL
    SAID, SI
    PLASTIC AND RECONSTRUCTIVE SURGERY, 1988, 81 (04) : 638 - 640
  • [43] CHOLERETIC EFFECT OF VASOACTIVE INTESTINAL PEPTIDE
    THULIN, L
    HELLGREN, M
    ACTA CHIRURGICA SCANDINAVICA, 1976, 142 (03): : 235 - 237
  • [44] Immunobiology of vasoactive intestinal peptide (VIP)
    Pozo, D
    Delgado, M
    Martínez, C
    Guerrero, JM
    Leceta, J
    Gomariz, RP
    Calvo, JR
    IMMUNOLOGY TODAY, 2000, 21 (01): : 7 - 11
  • [45] DIARRHEA, GANGLIONEUROBLASTOMA AND VASOACTIVE INTESTINAL PEPTIDE
    MITCHELL, C
    SINATRA, F
    GRIFFIN, R
    CRAST, F
    SUNSHINE, P
    CLINICAL RESEARCH, 1976, 24 (02): : A169 - A169
  • [46] EFFECT OF VASOACTIVE INTESTINAL PEPTIDE IN MAN
    KREJS, GJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1988, 527 : 501 - 507
  • [47] VASOACTIVE-INTESTINAL-PEPTIDE - A CHRONOIMMUNOMODULATOR
    GUGINI, P
    LUCIA, P
    DIPALMA, L
    POZZILLI, P
    RE, M
    CANOVA, R
    GASBARRONE, L
    CIANETTI, A
    BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1991, 46 (02): : 274 - 276
  • [48] Vasoactive intestinal peptide: cardiovascular effects
    Henning, RJ
    Sawmiller, DR
    CARDIOVASCULAR RESEARCH, 2001, 49 (01) : 27 - 37
  • [49] Vasoactive intestinal peptide is a local mediator in a gut-brain neural axis activating intestinal gluconeogenesis
    De Vadder, F.
    Plessier, F.
    Gautier-Stein, A.
    Mithieux, G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (03): : 443 - 448
  • [50] EFFECT OF INFUSED VASOACTIVE-INTESTINAL-PEPTIDE ON AIRWAY FUNCTION IN NORMAL SUBJECTS
    PALMER, JBD
    CUSS, FMC
    WARREN, JB
    BLANK, M
    BLOOM, SR
    BARNES, PJ
    THORAX, 1986, 41 (09) : 663 - 666